LZYY(SH:603368) Cai Jing Wang·2025-10-14 04:38Core Viewpoint - The company is focusing on transforming its business model from "pharmaceutical sales" to "health services" by implementing chronic disease management projects targeted at middle-aged and elderly populations, utilizing AI consultation and digital health services [1] Group 1: Business Strategy - The company aims to create a differentiated advantage through the implementation of chronic disease management projects and digital health services [1] - The strategy includes leveraging its self-operated internet hospital to provide online diagnosis, chronic disease prescription renewals, and health consultations [1] - The goal is to integrate online and offline medical services with retail pharmacy professional purchasing and health management services, establishing a comprehensive "new retail" ecosystem [1] Group 2: Financial Performance - In the first half of 2025, the company reported revenue of 10.301 billion yuan, a year-on-year decrease of 3.21% [1] - The net profit attributable to the parent company was 429 million yuan, reflecting a year-on-year decline of 7.52% [1]